(QURE) Uniqure - Performance 58.1% in 12m
QURE performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-49.96%
#68 in Peer-Group
Rel. Strength
89.05%
#840 in Stock-Universe
Total Return 12m
58.07%
#20 in Peer-Group
Total Return 5y
-67.32%
#76 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 27.9 |
| High / Low | USD |
|---|---|
| 52 Week High | 18.08 USD |
| 52 Week Low | 4.54 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 43.40 |
| Buy/Sell Signal +-5 | -1.73 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: QURE (58.1%) vs XBI (-12.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.31% | 59.8% | 74.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
4.3% | -9.7% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.02% | -7.68% | 38% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.08% | 26.2% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.29% | -9.49% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.7% | 37.9% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.29% | 46.5% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
0.46% | 28.5% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: QURE vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for QURE
| Total Return (including Dividends) | QURE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -6.13% | 4.10% | 4.77% |
| 3 Months | 57.03% | 13.70% | 16.02% |
| 12 Months | 58.07% | -12.86% | 12.44% |
| 5 Years | -67.32% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | QURE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -33.8% | 52.1% | 90.3% |
| 3 Months | 41.9% | 79.4% | 97.5% |
| 12 Months | 66.4% | -87.4% | 46.4% |
| 5 Years | -84.4% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th23.50 | -9.82% | -10.40% |
| 3 Month | %th83.00 | 38.11% | 35.35% |
| 12 Month | %th91.00 | 81.41% | 40.58% |
| 5 Years | %th62.00 | -58.13% | -84.64% |
FAQs
Does Uniqure (QURE) outperform the market?
Yes,
over the last 12 months QURE made 58.07%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.86%.
Over the last 3 months QURE made 57.03%, while XBI made 13.70%.
Performance Comparison QURE vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
QURE vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.2% | -10.9% | -3.5% | 46% |
| US NASDAQ 100 | QQQ | 0.2% | -11.4% | -5.5% | 46% |
| German DAX 40 | DAX | -0.2% | -9.2% | -15.6% | 28% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1% | -11.3% | -7.9% | 39% |
| Hongkong Hang Seng | HSI | -0.7% | -10.1% | -25.5% | 24% |
| India NIFTY 50 | INDA | 1.5% | -7.7% | -3.9% | 61% |
| Brasil Bovespa | EWZ | 4.4% | -5.8% | -18.5% | 57% |
QURE vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.6% | -9.7% | -6.8% | 34% |
| Consumer Discretionary | XLY | -0.8% | -10.9% | 4.2% | 41% |
| Consumer Staples | XLP | 2.2% | -6.6% | -2.5% | 50% |
| Energy | XLE | -2.8% | -8.1% | 4.1% | 58% |
| Financial | XLF | 1.6% | -10.9% | -5.8% | 35% |
| Health Care | XLV | 0% | -5.9% | 8% | 65% |
| Industrial | XLI | -0.2% | -11.7% | -9.3% | 36% |
| Materials | XLB | -0.5% | -11.4% | -4.1% | 55% |
| Real Estate | XLRE | 0.4% | -6.3% | -2% | 51% |
| Technology | XLK | 0.3% | -13.3% | -8.6% | 48% |
| Utilities | XLU | 0.1% | -8.1% | -7.5% | 36% |
| Aerospace & Defense | XAR | -0.5% | -13.4% | -23.5% | 11% |
| Biotech | XBI | -3.5% | -10.2% | 6.8% | 71% |
| Homebuilder | XHB | -2.9% | -17.5% | 3.1% | 61% |
| Retail | XRT | 0.2% | -12.9% | 1.4% | 52% |
QURE vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -0.4% | -2.48% | 10.4% | 62% |
| Natural Gas | UNG | 1.9% | 2.7% | 22.5% | 55% |
| Gold | GLD | 0.1% | -3.9% | -21.4% | 20% |
| Silver | SLV | -4.2% | -12.4% | -25.5% | 33% |
| Copper | CPER | -10.2% | -22.1% | -23% | 35% |
QURE vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1% | -5.9% | 1.8% | 62% |
| iShares High Yield Corp. Bond | HYG | 0.7% | -7.5% | -0.5% | 49% |